Experiment: 2KDG

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
2	3D_15N-separated_NOESY	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
3	2D 1H-15N HSQC	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
4	2D 1H-13C HSQC	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
5	3D HNCA	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
6	3D HN(CO)CA	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
7	3D HNCACB	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
8	3D CBCA(CO)NH	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
9	3D C(CO)NH	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
10	3D H(CCO)NH	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
11	3D HCCH-COSY	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
12	3D iHNCA	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
13	2D 1H-13C HSQC (arom)	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
14	(HB)CB(CGCD)HD	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293
15	(HB)CB(CGCDCE)HE	0.5mM [U-13C; U-15N] Myotilin 249-344-1, 20mM potassium phosphate-2, 140mM sodium chloride-3, 1mM DTT-4	90% H2O/10% D2O	140	6.7	ambient	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY	800
2	Varian	UNITY	500

NMR Refinement
Method	Details	Software
molecular dynamics	Born implicit solvent model	VNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations, structures with the lowest energy
Conformers Calculated Total Number	40
Conformers Submitted Total Number	25
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	Dihedral angle restraints were extracted from alpha and beta carbon chemical shifts using TALOS program

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	VNMR	6.1	Varian Inc
2	data analysis	Sparky	3.106	T. D. Goddard and D. G. Kneller
3	data analysis	TALOS		Gabriel Cornilescu, Frank Delaglio, and Ad Bax
4	structure solution	CYANA	2.1	Guntert, P., Mumenthaler, C. & Wuthrich, K.
5	refinement	Amber	8.0	Case, D.A et al.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.